Increasingly complex monoclonal antibody molecules will require the right “tool box” for scaling up manufacturing.
Now that high yields have been achieved for the first generation of monoclonal antibodies, the next challenge will be developing ways to produce larger quantities of even more complex antibody formats. These increasingly complex molecules will require the right “tool box” for scaling up manufacturing.
Read this article in BioPharm International's Outsourcing Resources 2019 eBook.
BioPharm International
eBook: Outsourcing Resources 2019
April 2019
Pages: 16–19
When referring to this article, please cite it as Andy Racher, "Complex and Customized: Manufacturing New Molecular Formats,"BioPharm International's Outsourcing Resources eBook (April 2019).
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.